Public Sector & Education
🟢 SERP-Grounded (Light Telemetry)

Voltaren

Programmatic AI Search & Model Visibility Audit

Share of Model (SOM)
0.3%
+0.1% 30-Day Momentum
🧠 Neural Valency:Dominant

Algorithmic Threat Detection

Primary Competitor Threat
Topical NSAIDs
Competitor Displacement Rate
0.3%

Competitors are displacing Voltaren in 0.3% of high-intent buyer queries.

Algorithmic Rationale: Voltaren benefits from strong brand recognition and a well-established presence in topical pain relief. However, emerging direct-to-consumer brands offering similar formulations at competitive prices pose a growing threat.
Missing AI Citations:
[webmd.com][medicalnewstoday.com]
⚠️ Identified Vulnerability:Price Sensitivity
Primary Threat Identified:Topical NSAIDs
Target Persona:Individuals with Joint Pain
🚨 Threat Velocity:5/10
Unlock Full Threat Report (30 Free Credits)